Source: Eur Respir J 2014; 44: 985-993



Rating:

Share or cite this content

Citations should be made in the following way:
Su Robert, Li Michael M., Bhakta Nirav R., Solberg Owen D., Darnell Eli P.B., Ramstein Joris, Garudadri Suresh, Ho Melissa, Woodruff Prescott G., Koth Laura L.. Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes. Eur Respir J 2014; 44: 985-993

Member's Comments

No comment yet.

Related content which might interest you: Longitudinal validation of clinical COPD phenotypes identified by cluster analysis Source: Annual Congress 2011 - COPD diagnosis Year: 2011 The landscape of transcriptomic and proteomic studies in sarcoidosis Source: ERJ Open Res, 8 (1) 00621-2021; 10.1183/23120541.00621-2021 Year: 2022 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Prediction of longitudinal inflammatory phenotypes using baseline sputum transcriptomics in UBIOPRED Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Comparative analysis of the plasma metabolomics in rodent models of pulmonary hypertension and patients with IPAH shows different metabolic signatures Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Comparative analysis of routine biochemistry data and neurohormonal markers in patients with different forms of pulmonary hypertension Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases Year: 2010 Integrative clustering analysis to discover novel IPF disease subtypes in the IPF-PRO Registry Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis Year: 2020 Proteomic analysis of sputum from adults with cystic fibrosis and COPD: identification of potential biomarkers for disease monitoring Source: Eur Respir J 2006; 28: Suppl. 50, 152s Year: 2006 Longitudinal measurements of blood eosinophils in relation to COPD outcomes Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Longitudinal assessment in COPD patients: multidimensional variability and outcomes Source: Eur Respir J 2014; 43: 745-753 Year: 2014 Identification and analysis of clinical phenotypes in COPD patients: PALOMB Cohort Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Combined genome-wide transcriptomic and epigenetic profiling across disease stages identifies novel regulators of COPD in human lung fibroblasts Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 Differential mast cell activation by transcriptomic signature analysis in the U-BIOPRED severe asthma cohort Source: Virtual Congress 2020 – Novel methods, diagnostics and biomarkers of chronic lung diseases Year: 2020 Detailed physiological profiling of patients for a study investigating the airway microbiome Source: International Congress 2018 – Innovations in equipment and their application Year: 2018 New approaches to tuberculosis diagnosis through the study of metabolomic profile in urine Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 Serum microRNA signatures identified in a genome-wide profiling predict the mortality of patients with sepsis Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011 Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015